REPLICATE ® System | Updates
This investment carries considerable risks and may lead to a complete loss of the capital invested. More
By Lea Ellermeier & Rüdger Rubbert

Letter of intent regarding a major contract for the US market entry has been signed

Public
Public

Dear Companists,

Every new investment comment puts a smile on all of our faces. Thank you very much. This is what we intend to achieve for you with our update: We come bearing good news!

The letter of intent regarding a major contract with a volume beyond 15 million euro per year has been signed. With the conclusion of the FDA approval, 300 dentists across the US will start using the REPLICATE System.

Due to non-disclosure agreements we cannot go into details about the deal and the partner company. The cooperating partner is a leading provider of dental services and operates over 150 dental practices. The forthcoming partner of the NDI AG enables an exclusive market access to 300 dentists in one go. A purchase volume of more than 15 million euro for the REPLICATE System has been agreed.

 

Inspection of a finished REPLICATE tooth

 

The marketable REPLICATE System has been successfully used for 4 years and has already been granted approval in the EU. With the conclusion of the FDA approval (planned for 2018) the REPLICATE System can get off to an explosive start in the US.

Such major contracts ensure quick market entries with exceptionally high growth potentials in new countries. The cooperation partner has paved the way for NDI to enter the US – the world’s largest homogeneous market for dentistry.

We look forward to capturing the US market together with our Companists.

 

Kind regards,

Lea and Rüdger



Comments

Only registered Companists can comment. Please log in to leave a comment.

NOTE:

Investments in crowdfunding projects offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, these investments are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by splitting their investment amount between crowdfunding campaigns rather than investing all of it in one crowdfunding campaign. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the Companists are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the Companists – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, crowdfunding investments are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

1052

Companists

2,039,600 €

Invested ( € 1M co-invested )

3.23 %

Share offered

50

Days Left

Invest

Latest Investment: 60 minutes ago

Largest Investment: 10,000 €

Data

Participation Rate for Each € 100 Invested

45,000,000 € (More Info)

Company Valuation

100,000 €

Investment Threshold

1,500,000 €

Funding Goal

Probability of Default

Contact Details
Natural Dental Implants AG
Dieffenbachstraße 33
10967 Berlin
Germany

Email: investor-relations@replicatetooth.com
Website: www.replicatetooth.com
Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used.

Follow us

Contact Us
Your contact for all questions about investing on Companisto:
Andreas Riedel
Investor Relations

Toll-free phone number for investors

0800 - 100 26 70 (DE)
0800 - 10 02 67 (AT)
0800 - 10 02 67 (CH)

Service hours Mo-Fr 9 a.m.- 7 p.m.

Companisto GmbH
Köpenicker Str. 154
10997 Berlin
TÜV geprüftes Online-Portal | Companisto
Source: Own research. Based on data from the German Private Equity and Venture Capital Association - BVK, among others.
Investor Support